Literature DB >> 3496383

Androgen receptors in human thymocytes.

W J Kovacs, N J Olsen.   

Abstract

On the basis of a variety of evidence androgenic hormones are thought to exert modulatory effects on immune function. Because specific actions of these hormones are exerted through receptor-mediated mechanisms, we have examined the human thymus gland for the presence of specific high-affinity androgen receptors. Cytosolic extracts of whole human thymus were found to contain 6.5 (+/- 2.6) fmol of specific [3H]methyltrienolone binding per mg protein. The receptor sedimented at 8s on sucrose density gradient centrifugation analysis. Thymic fibroblast lines derived from these glands did not express sufficient receptor content to account for the findings in whole thymus cytosolic extracts. Purified thymocyte preparations (greater than 99.3% pure as assessed by flow cytometry with monoclonal anti-thymocyte marker OKT11) contained 3.34 (+/- 1.2) fmol receptor per mg cytosolic protein. Mature peripheral blood lymphocytes, human T cells obtained from thoracic duct drainage, and the human T cell line Jurkat were not found to contain these receptors. These studies demonstrate for the first time that a high affinity androgen receptor is present in maturing human thymocytes. A functional role for these receptors is suggested by dihydrotestosterone-mediated decreases in interleukin 2-like activity produced by cultured human thymocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496383

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Effects of androgens on T and B lymphocyte development.

Authors:  N J Olsen; W J Kovacs
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

3.  CCL25 increases thymopoiesis after androgen withdrawal.

Authors:  Kirsten M Williams; Philip J Lucas; Catherine V Bare; Jiun Wang; Yu-Waye Chu; Ezekiel Tayler; Veena Kapoor; Ronald E Gress
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 4.  Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients.

Authors:  E Velardi; J A Dudakov; M R M van den Brink
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

5.  A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity.

Authors:  L Mirone; L Altomonte; P D'Agostino; A Zoli; A Barini; M Magaro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

6.  Sex and age as determinants of rat T-cell phenotypic characteristics: influence of peripubertal gonadectomy.

Authors:  Nevena Arsenović-Ranin; Duško Kosec; Ivan Pilipović; Mirjana Nacka-Aleksić; Biljana Bufan; Zorica Stojić-Vukanić; Gordana Leposavić
Journal:  Mol Cell Biochem       Date:  2017-03-09       Impact factor: 3.396

Review 7.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

8.  Studies of immunological function in mice with defective androgen action. Distinction between alterations in immune function due to hormonal insensitivity and alterations due to other genetic factors.

Authors:  N J Olsen; M B Watson; W J Kovacs
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

9.  Androgen-dependent immune modulation in parasitic infection.

Authors:  Julie Sellau; Marie Groneberg; Hannelore Lotter
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

10.  Effects of testosterone in the treatment of immune-mediated sensorineural hearing loss.

Authors:  Sang W Yeo; Ki-Hong Chang; Shi-Nae Park; Byung-Do Suh
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.